BioXcel Therapeutics Competitors and Similar CompaniesClear all
BioXcel Therapeutics's competitors and similar companies include Merus and Cue Biopharma.
 BioXcel Therapeutics BioXcel Therapeutics is a biopharmaceutical company that focuses on artificial intelligence for neuroscience. |  Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  Cue Biopharma Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease. | |
Founding Date | Founding Date 2017 | Founding Date 2003 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New Haven, US HQ | Locations Utrecht, NL HQ Cambridge, US | Locations Cambridge, US HQ |
Employees | Employees 29 | Employees 260 | Employees 4664% increase |
Valuation ($) | Valuation ($) 29 m | Valuation ($) 3.6 b | Valuation ($) 107.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $642k (FY, 2025) | Revenue (est.) $36.1m (FY, 2024) | Revenue (est.) $27.5m (FY, 2025) |
Cost of goods | Cost of goods $164k (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $478k (FY, 2025) | Gross profit $36.1m (FY, 2024) | Gross profit N/A |
Net income | Net income ($69.9m) (FY, 2025) | Net income ($215.3m) (FY, 2024) | Net income ($26.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Merus
HQ
Utrecht, NL
Employees
260
Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View companyCue Biopharma
HQ
Cambridge, US
Employees
46
Cue Biopharma is an immunotherapy company developing biologics engineered to selectively modulate disease-relevant T cells for the treatment of cancer and autoimmune disease.
View company